Logo image
Fresh Embryo Transfer Cycle Characteristics and Outcomes Following In Vitro Fertilization via Intracytoplasmic Sperm Injection Among Patients With and Without COVID-19 Vaccination
Journal article   Open access   Peer reviewed

Fresh Embryo Transfer Cycle Characteristics and Outcomes Following In Vitro Fertilization via Intracytoplasmic Sperm Injection Among Patients With and Without COVID-19 Vaccination

Emily Jacobs, Karen Summers, Amy Sparks and Rachel Mejia
JAMA network open, Vol.5(4), pp.e228625-e228625
04/22/2022
DOI: 10.1001/jamanetworkopen.2022.8625
PMCID: PMC9034396
PMID: 35452110
url
https://doi.org/10.1001/jamanetworkopen.2022.8625View
Published (Version of record) Open Access

Abstract

Women of reproductive age have been at the forefront of COVID-19 vaccine hesitancy, citing concerns about the vaccine’s effect on future fertility, current pregnancy, and breastfeeding (among others).1 As of February 2022, only 57% of pregnant patients were fully vaccinated against COVID-19 prior to becoming pregnant, a rate that lags that of the general population.2 To date, current literature surrounding COVID-19 vaccination and potential associations with infertility have been performed mainly in frozen embryo transfer cycles or in vitro fertilization cycles (IVF) using intracytoplasmic sperm injection (ICSI), both of which do not occur in in vivo conception.3,4 The aim of this study was to investigate the association of COVID-19 vaccination status with IVF-fresh embryo transfer cycle stimulation characteristics and clinical outcomes
General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal Science & Technology COVID-19

Details

Metrics

Logo image